Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-25 @ 3:02 AM
NCT ID:
NCT01132833
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Newly diagnosed; relapsed, or refractory multiple myeloma
PATIENT CHARACTERISTICS:
* Central venous access devices allowed
* Recruited by the Division of Hematology/Oncology and the Lineberger Comprehensive Cancer Center at the University of North Carolina
* No history of venous thromboembolism
* No hospitalization for \> 2 days within the past month
* Not pregnant
* No patient who refuses or is deemed unsuitable for chemotherapy
PRIOR CONCURRENT THERAPY:
* No surgery within the past month
* Bone marrow biopsies, central venous line placement and diagnostic biopsies by surgery or fine-needle aspiration allowed
* \* No concurrent anticoagulation therapy
* Concurrent antiplatelet agents, such as aspirin and/or clopidogrel, allowed
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01132833
Study Brief:
Protocol Section:
NCT01132833